Lyophilisation, commonly known as freeze-drying, plays a pivotal role in the field of biopharmaceutics, revolutionizing the preservation of sensitive biological materials. This sophisticated process involves freezing a substance and then removing the frozen solvent through sublimation, resulting in a stable, dry product with an extended shelf life.
In biopharmaceutics, lyophilisation is instrumental in preserving the integrity of delicate biomolecules such as proteins, enzymes, and vaccines. This method mitigates the risks of degradation and maintains the bioactivity of these substances, ensuring their efficacy upon reconstitution. The versatility of lyophilisation makes it an indispensable tool in pharmaceuticals, allowing for the development of injectable drugs, oral tablets, and other dosage forms.
Beyond stability, lyophilisation addresses challenges associated with transportation and storage, particularly for biopharmaceuticals that require stringent temperature control. This process facilitates the creation of lightweight, transportable formulations without compromising the therapeutic potential of the drug.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia